MYELOID LEUKEMIA OF DOWN SYNDROME - MONITORING OF MINIMAL RESIDUAL DISEASE

被引：0
|
作者：
Reinhardt, D. [1 ]
Reinhardt, K. [1 ]
Boehmer, K. [1 ]
Sander, A. [1 ]
Neuhoff, C. [1 ]
Creutzig, U. [2 ]
机构：
[1] Hannover Med Sch, D-3000 Hannover, Germany
[2] Univ childrens Hosp, Munster, Germany
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0067
引用
收藏
页码：27 / 27
页数：1
相关论文
共 50 条
  • [21] Introducing minimal residual disease in acute myeloid leukemia
    Ofran, Yishai
    Rowe, Jacob M.
    CURRENT OPINION IN HEMATOLOGY, 2015, 22 (02) : 139 - 145
  • [22] Molecular Minimal Residual Disease in Acute Myeloid Leukemia
    Mauvieux, Laurent
    Miguet, Laurent
    Fornecker, Luc
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (25): : 2442 - +
  • [23] MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA PATIENTS
    Van der Velden, Vincent
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2009, 76B (06) : 416 - 416
  • [24] Minimal residual disease in patients with acute myeloid leukemia
    Galtseva, IV
    GEMATOLOGIYA I TRANSFUZIOLOGIYA, 1998, 43 (01): : 10 - 11
  • [25] Assessment of minimal residual disease in acute myeloid leukemia
    Grimwade, David
    Vyas, Paresh
    Freeman, Sylvie
    CURRENT OPINION IN ONCOLOGY, 2010, 22 (06) : 656 - 663
  • [26] A novel deep targeted sequencing method for minimal residual disease monitoring in acute myeloid leukemia
    Onecha, Esther
    Linares, Maria
    Rapado, Inmaculada
    Ruiz-Heredia, Yanira
    Martinez-Sanchez, Pilar
    Cedena, Teresa
    Pratcorona, Marta
    Perez Oteyza, Jaime
    Herrera, Pilar
    Barragan, Eva
    Montesinos, Pau
    Garcia Vela, Jose Antonio
    Magro, Elena
    Anguita, Eduardo
    Figuera, Angela
    Riaza, Rosalia
    Martinez-Barranco, Pilar
    Sanchez-Vega, Beatriz
    Nomdedeu, Josep
    Gallardo, Miguel
    Martinez-Lopez, Joaquin
    Ayala, Rosa
    HAEMATOLOGICA, 2019, 104 (02) : 288 - 296
  • [27] DNA-Based Monitoring of Minimal Residual Disease(MRD) in Chronic Myeloid Leukemia(CML)
    Morley, Alexander A.
    Bartley, Paul
    Ross, David M.
    Latham, Sue
    Martin-Harris, Henry
    Budgen, Brad
    Wilczek, Vicki
    Branford, Susan
    Hughes, Timothy
    BLOOD, 2008, 112 (11) : 406 - 406
  • [28] Clinical relevance of minimal residual disease monitoring in adult patients with acute myeloid leukemia.
    Venditti, A
    Tamburini, A
    Buccisano, F
    Del Poeta, G
    Maurillo, L
    Scornajenghi, KA
    Panetta, P
    BLOOD, 2001, 98 (11) : 580A - 580A
  • [29] Next generation sequencing-based monitoring for minimal residual disease in acute myeloid leukemia
    Ok, Chi Young
    Salim, Alaa
    Luthra, Rajyalakshmi
    Patel, Keyur
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 : S196 - S196
  • [30] The impact of cell heterogeneity and immunophenotypic changes on monitoring minimal residual disease in acute myeloid leukemia
    Zeleznikova, T.
    Babusikova, O.
    NEOPLASMA, 2006, 53 (06) : 500 - 506
12345